rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1997-9-4
|
pubmed:abstractText |
Obliterative bronchiolitis (OB) is a disease affecting a large percentage of lung and heart-lung transplant recipients. Histologically, the disease is characterized by inflammation, cellular proliferation, and obliteration of terminal airways.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0041-1337
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
270-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9256186-Bronchiolitis Obliterans,
pubmed-meshheading:9256186-Endothelium, Vascular,
pubmed-meshheading:9256186-Humans,
pubmed-meshheading:9256186-Immunohistochemistry,
pubmed-meshheading:9256186-Lung,
pubmed-meshheading:9256186-Lung Transplantation,
pubmed-meshheading:9256186-Macrophages, Alveolar,
pubmed-meshheading:9256186-Nitrates,
pubmed-meshheading:9256186-Nitric Oxide Synthase
|
pubmed:year |
1997
|
pubmed:articleTitle |
Immunohistochemical localization of nitric oxide synthase and the oxidant peroxynitrite in lung transplant recipients with obliterative bronchiolitis.
|
pubmed:affiliation |
The Montreal General Hospital, McGill University, and GenPath Laboratories, Quebec, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|